Skip to main content
. 2020 Mar 20;10(3):560. doi: 10.3390/nano10030560

Figure 3.

Figure 3

Schematic representation of (A) nanomaterials with inherent antimicrobial properties, and (B) nanoparticle-based antimicrobial drugs.